Impact of Rehabilitation on Breast Cancer Related Fatigue: A Pilot Study.
breast cancer
fatigue
muscle performance
muscle strength
precision medicine
quality of life
rehabilitation
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2020
2020
Historique:
received:
28
04
2020
accepted:
17
09
2020
entrez:
16
11
2020
pubmed:
17
11
2020
medline:
17
11
2020
Statut:
epublish
Résumé
Breast cancer fatigue (BCF) is a complex and multidimensional condition characterized by a persistent sense of physical and/or mental stiffness, resulting in a substantial impairment of health-related quality of life in breast cancer survivors. Aim of this prospective cohort study was to evaluate the feasibility and the effectiveness of a 4-week rehabilitation protocol on BCF, muscle mass, strength, physical performance, and quality of life in breast cancer (BC) survivors. We recruited adult BC women with a diagnosis of BCF, according to the International Classification of Diseases 10 criteria, referred to the Outpatient Service for Oncological Rehabilitation of a University Hospital. All participants performed a specific physical exercise rehabilitative protocol consisting of 60-min sessions repeated 2 times/week for 4 weeks. All outcomes were evaluated at the baseline (T0), at the end of the 4-week rehabilitation treatment (T1), and at 2 months follow up (T2). The primary outcome measure was the Brief Fatigue Inventory (BFI); secondary outcomes included: Fat-Free Mass and Fat Mass, assessed by Bioelectrical Impedance Analysis (BIA); Hand Grip Strength Test (HGS); Short Physical Performance Battery (SPPB); 10-meter walking test (10 MWT); 6-min walking test (6 MWT); European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). Thirty-six women (mean age: 55.17 ± 7.76 years) were enrolled in the study. Significant reduction of BCF was observed both after the 4-week rehabilitation treatment (T1) (BFI: 5.4 ± 1.6 vs. 4.2 ± 1.7;
Identifiants
pubmed: 33194622
doi: 10.3389/fonc.2020.556718
pmc: PMC7609789
doi:
Types de publication
Journal Article
Langues
eng
Pagination
556718Informations de copyright
Copyright © 2020 Invernizzi, de Sire, Lippi, Venetis, Sajjadi, Gimigliano, Gennari, Criscitiello, Cisari and Fusco.
Références
Biores Open Access. 2019 Jul 30;8(1):121-128
pubmed: 31367476
Front Oncol. 2020 Jun 16;10:864
pubmed: 32612947
Oncologist. 2020 Apr;25(4):e610-e611
pubmed: 31943517
Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):123-33
pubmed: 21051654
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
J Cachexia Sarcopenia Muscle. 2013 Sep;4(3):239-43
pubmed: 23529675
Arch Gerontol Geriatr. 2019 May - Jun;82:273-278
pubmed: 30889410
Physiother Theory Pract. 2020 Dec;36(12):1348-1353
pubmed: 30704332
BMC Cancer. 2018 Sep 29;18(1):935
pubmed: 30268112
Curr Treat Options Oncol. 2020 Feb 5;21(2):17
pubmed: 32025928
Breast Care (Basel). 2018 Apr;13(2):93-101
pubmed: 29887785
Ageing Res Rev. 2020 Mar;58:101025
pubmed: 32018055
J Natl Compr Canc Netw. 2015 Aug;13(8):1012-39
pubmed: 26285247
BMC Cancer. 2015 Feb 21;15:77
pubmed: 25885168
Breast. 2019 Apr;44:15-23
pubmed: 30580170
Support Care Cancer. 2002 Jul;10(5):389-98
pubmed: 12136222
Cancer. 1999 Mar 1;85(5):1186-96
pubmed: 10091805
Med Sci Sports Exerc. 2010 Jul;42(7):1409-26
pubmed: 20559064
Cancer Treat Rev. 2019 Mar;74:1-14
pubmed: 30658289
Eur Rev Med Pharmacol Sci. 2020 Aug;24(15):8028-8035
pubmed: 32767329
Cancers (Basel). 2020 Jan 13;12(1):
pubmed: 31941005
Cancers (Basel). 2019 Nov 28;11(12):
pubmed: 31795208
J Cancer Res Clin Oncol. 2019 Oct;145(10):2583-2593
pubmed: 31401675
Eur Rev Med Pharmacol Sci. 2015 Jul;19(13):2446-51
pubmed: 26214781
Burns. 2015 Aug;41(5):990-7
pubmed: 25499405
Br J Sports Med. 2016 Mar;50(6):339-45
pubmed: 26385207
Front Endocrinol (Lausanne). 2020 Apr 15;11:204
pubmed: 32351450
Support Care Cancer. 2018 Oct;26(10):3353-3364
pubmed: 29961146
Muscle Nerve. 2011 Jan;43(1):94-102
pubmed: 21171100
Cancer Manag Res. 2020 Jan 30;12:675-686
pubmed: 32099464
Physiotherapy. 2018 Dec;104(4):400-407
pubmed: 30477677
Breast. 2017 Jun;33:166-177
pubmed: 28415013
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Curr Opin Clin Nutr Metab Care. 2015 May;18(3):221-5
pubmed: 25769061
Antioxid Redox Signal. 2020 Sep 10;33(8):542-558
pubmed: 32037856
Curr Osteoporos Rep. 2020 Aug;18(4):422-431
pubmed: 32519284
Skelet Muscle. 2012 Jul 06;2:14
pubmed: 22769563
Nutrients. 2020 Feb 22;12(2):
pubmed: 32098380
Cancer Immunol Immunother. 2017 May;66(5):667-671
pubmed: 28324125
JAMA. 2005 May 25;293(20):2479-86
pubmed: 15914748
Cochrane Database Syst Rev. 2012 Nov 14;11:CD006145
pubmed: 23152233
Aging Clin Exp Res. 2014 Aug;26(4):341-51
pubmed: 24347122
J Physiother. 2018 Jan;64(1):61
pubmed: 28645532
Biores Open Access. 2019 Jul 03;8(1):101-110
pubmed: 31275735
Nutrition. 2001 Mar;17(3):248-53
pubmed: 11312069
Cells. 2019 Jul 18;8(7):
pubmed: 31323874
Diabetes Obes Metab. 2013 Sep;15 Suppl 3:51-60
pubmed: 24003921
Brain Behav Immun. 2019 Oct;81:92-104
pubmed: 31454519
Curr Sports Med Rep. 2013 Jul-Aug;12(4):215-7
pubmed: 23851406
J Clin Med. 2020 Jan 09;9(1):
pubmed: 31936624
J Clin Oncol. 2014 Jun 10;32(17):1840-50
pubmed: 24733803
Cochrane Database Syst Rev. 2011 Jul 06;(7):CD000333
pubmed: 21735380
Neuromuscul Disord. 2017 Oct;27(10):879-882
pubmed: 28803817